OXYGEN TENSION AND ENDOTHELIUM-DEPENDENT VASODILATION
氧张力和内皮依赖性血管舒张
基本信息
- 批准号:3471728
- 负责人:
- 金额:$ 11.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 1993-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The role of the endothelium has taken on increasing significance
in vascular pharmacology and physiology in the past several years
with the discovery that numerous endogenous and exogenous
vasodilators exert their action on vascular smooth muscle by
releasing from the endothelium a substance termed endothelium-
dependent relaxing factor (EDRF). The production of EDRF is
calcium dependent; it has a short biologic half-life; and its
relaxing action on vascular smooth muscle correlates with an
increase in muscle cyclic GMP concentration. Several studies
have implicated the importance of oxygen tension in the stability
of the relaxation responses induced by EDRF.
The proposed research plan will investigate the inhibition of
endothelium dependent relaxation by hypoxia. The oxygen
sensitivity of these responses could be due to an effect on factor
production, to the stability of EDRF once produced, to the
reactivity of the vascular smooth muscle where it acts, or to
some combination of these events. An experimental system will
be used which allows transfer of EDRF from cultured pulmonary
artery endothelial cells to one of three bioassays: relaxation of a
de-endothelialized vascular ring, increase in cyclic GMP levels in
cultured-vascular smooth muscle, or activation of guanylate
cyclase. Separate manipulation of the oxygen tensions of the
endothelial cells, of EDRF in solution, and of the bioassay
preparations will allow us to investigate the sites and mechanisms
of oxygen interactions with EDRF. The effects of varying oxygen
tensions on the increase in endothelial cell cytoplasmic calcium
concentration which normally accompanies EDRF release also will
be determined.
In addition to providing further insight into the nature of EDRF,
these studies will increase our understanding of the potential role
of EDRF in the normal and diseased pulmonary circulation
including regulation of basal tone, hypoxic pulmonary
vasoconstriction, pulmonary hypertension, and adult respiratory
distress syndrome.
内皮细胞的作用越来越重要
血管药理学和生理学的研究进展
随着许多内源性和外源性的发现,
血管扩张剂通过以下方式对血管平滑肌发挥作用:
从内皮释放一种称为内皮的物质,
依赖性舒张因子(EDRF)。 EDRF的生产是
钙依赖性;它具有短的生物半衰期;其
对血管平滑肌的舒张作用与
增加肌肉环GMP浓度。 几项研究
暗示了氧张力在稳定性中的重要性
EDRF诱导的弛豫反应。
拟议的研究计划将研究抑制
缺氧引起的内皮依赖性舒张。 氧
这些反应的敏感性可能是由于对因素的影响,
生产,EDRF一旦生产的稳定性,
血管平滑肌作用处的反应性,或
这些事件的组合。 一个实验系统将
可以将EDRF从培养的肺细胞中转移
动脉内皮细胞的三个生物测定之一:松弛的
去内皮化的血管环,
培养的血管平滑肌,或激活鸟苷酸
环化酶 单独操纵的氧张力的
内皮细胞,EDRF溶液,和生物测定
准备工作将使我们能够调查的网站和机制
氧与EDRF的相互作用。 不同氧气的影响
张力对内皮细胞胞浆钙离子浓度的影响
通常伴随EDRF释放的浓度也将
被确定。
除了提供对EDRF性质的进一步了解之外,
这些研究将增加我们对
正常和病变肺循环中EDRF的浓度
包括调节基础张力、低氧性肺动脉高压
血管收缩、肺动脉高压和成人呼吸道疾病
痛苦综合症
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Desmopressin is a potent vasorelaxant of aorta and pulmonary artery isolated from rabbit and rat.
去氨加压素是从兔和大鼠中分离出来的一种有效的主动脉和肺动脉血管舒张剂。
- DOI:10.1097/00000542-199005000-00016
- 发表时间:1990
- 期刊:
- 影响因子:8.8
- 作者:Johns,RA
- 通讯作者:Johns,RA
NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
NG-monomethyl L-arginine 通过内皮细胞特有的作用抑制内皮细胞和血管平滑肌细胞共培养物中内皮衍生的松弛因子刺激的环 GMP 积累。
- DOI:10.1161/01.res.67.4.979
- 发表时间:1990
- 期刊:
- 影响因子:20.1
- 作者:Johns,RA;Peach,MJ;Linden,J;Tichotsky,A
- 通讯作者:Tichotsky,A
Local anesthetics inhibit endothelium-dependent vasodilation.
局部麻醉药抑制内皮依赖性血管舒张。
- DOI:10.1097/00000542-198905000-00017
- 发表时间:1989
- 期刊:
- 影响因子:8.8
- 作者:Johns,RA
- 通讯作者:Johns,RA
Vascular effects of 2-chloroprocaine and sodium metabisulfite on isolated rat aortic rings.
2-氯普鲁卡因和焦亚硫酸钠对离体大鼠主动脉环的血管作用。
- DOI:
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Wills,MH;Johns,RA;Stone,DJ;Moscicki,JC;Difazio,CA
- 通讯作者:Difazio,CA
Halothane, enflurane, and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production in rat thoracic aorta.
氟烷、安氟烷和异氟烷可减弱大鼠胸主动脉中受体和非受体介导的 EDRF 产生。
- DOI:10.1097/00000542-199206000-00023
- 发表时间:1992
- 期刊:
- 影响因子:8.8
- 作者:Uggeri,MJ;Proctor,GJ;Johns,RA
- 通讯作者:Johns,RA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger A Johns其他文献
Increased Pulmonary Blood Flow as a Regulator of Pulmonary Vascular Remodeling: Role of eNOS ♦ 105
- DOI:
10.1203/00006450-199704001-00126 - 发表时间:
1997-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Allen D Everett;Timothy D Le Cras;Chun Xue;Roger A Johns - 通讯作者:
Roger A Johns
Roger A Johns的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger A Johns', 18)}}的其他基金
Resistin regulates NLRP3 inflammasome in pulmonary hypertension
抵抗素调节肺动脉高压中的 NLRP3 炎性体
- 批准号:
10567914 - 财政年份:2023
- 资助金额:
$ 11.56万 - 项目类别:
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
- 批准号:
9976575 - 财政年份:2018
- 资助金额:
$ 11.56万 - 项目类别:
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
- 批准号:
10206240 - 财政年份:2018
- 资助金额:
$ 11.56万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10390873 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
- 批准号:
8757198 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
- 批准号:
9016565 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
- 批准号:
9335421 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10649603 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10212402 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
- 批准号:
8673354 - 财政年份:2014
- 资助金额:
$ 11.56万 - 项目类别:














{{item.name}}会员




